Malta’s AquaBioTech Group signed a turnkey contract for the design, supply, installation, and commissioning of a RAS broodstock, hatchery and live feed facility for barramundi.
This new generation of diets brings new capacities to optimize reproductive rates in fish farms and RAS centers.
The partnership aims to bolster trout availability throughout the year without compromising quality.
Aqsen Innovations is aiming for the technology to be priced at just 25% to 30% of equivalent products.
The company has expanded its presence in the South American region with the appointment of Constanza Fontaine as sales and service manager in Chile.
Owners still considering selling its Greek business.
Skretting Nigeria Limited produces catfish superior feeds, broodstock feeds and tilapia catering for the entire fish life cycle.
Gustavo Bozano has been appointed as new CEO of GenoMar Genetics Group.
A collaboration between Ace Aquatec and Tiny Fish is advancing Scottish salmon’s circular economy by helping the sector gain access to new premium food markets for its smallest fish.
A study concluded that krill meal inclusion resulted in positive effects on Nile tilapia’s reproductive performance and higher survival of larvae.
The company partnered with Cermaq to deliver aquafeeds with insect meal in 2023 and has also incorporated this ingredient in its new Coho diets for freshwater.
A consortium of UK academics and aquaculture partners is exploring the best conditions for delivering vaccines against Aeromonas salmonicida to ballan wrasse.
Spring Genetics will receive specific welfare-focused training from FAI experts as well as use of FAI’s Tilapia Welfare assessment app.
Ridgeway Biologicals and Mowi Scotland developed a new vaccine strategy to safeguard salmon against the bacteria Yersinia ruckeri.
The government has approved a project to breed a snapper that is more resistant to disease, grows faster, and can thrive in warmer water.
The technology builds on more than 25 years of experience in measuring fish in cages, and it will be used in land-based aquaculture facilities.
A public-private initiative aims to implement new solutions to prevent bacterial diseases and reduce the use of antibiotics.
The technology could be scaled up to make mass antigens available to later be applied via salmon feeds as an oral vaccine.
Troutlodge achieved a milestone in year-round availability of Bacterial Cold Water Disease resistant trout eggs for customers all over the world.
A strain was designed to thrive in brackish water and estuarine environments to prevent mass mortalities due to saltwater intrusions.
